Cost Effectiveness of Asthma Management Strategies

Author： Thomas M.   Haughney J.   Price D.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.11, 2002-01, pp. : 789-789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of an Economic Model to Assess the Cost Effectiveness of Asthma Management Strategies

By Price M.J.  

PharmacoEconomics, Vol. 20, Iss. 3, 2002-01 ,pp. : 183-194

Adis International

Access to resources Recommend Favorite

Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia: A Cost-Effectiveness Analysis

By Patrick Amanda R.   Winkelmayer Wolfgang C.   Avorn Jerry   Fischer Michael A.  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 949-961

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma

By Heaton Pamela C.  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 727-742

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Fluticasone and Budesonide in Patients with Moderate Asthma

By Steinmetz K-O.  

Clinical Drug Investigation, Vol. 16, Iss. 2, 1998-08 ,pp. : 117-123

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Model of Cytomegalovirus Management Strategies in Renal Transplantation: Comparing Valaciclovir Prophylaxis with Current Practice

By Mauskopf J.A.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 239-251

Adis International

Access to resources Recommend Favorite